Stent procedure complicated by thrombus formation distal to the lesion within a muscle bridge

M Agirbasli1, W B Hillegass, G D Chapman

  • 1Vanderbilt University Medical Center, Cardiology Division, Department of Medicine, Nashville, Tennessee 37232-6300, USA.

Insights

Myocardial bridging, a congenital anomaly, can complicate coronary interventions. Prompt treatment with glycoprotein IIb/IIIa antagonists resolved thrombus in a patient with left anterior descending artery intervention.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Congenital Anomalies

Background:

  • Myocardial bridging is a congenital anomaly where coronary arteries penetrate cardiac muscle.
  • Historically considered benign, it's now associated with ischemia, infarction, and arrhythmias.

Observation:

  • A case involving percutaneous intervention on the left anterior descending artery presented with thrombus formation distal to the lesion within a myocardial bridge.
  • Complete angiographic resolution of thrombus and restoration of antegrade blood flow were achieved with abciximab infusion.

Findings:

  • The case highlights thrombus formation in a myocardial bridge distal to a treated coronary lesion.
  • Glycoprotein IIb/IIIa antagonist (abciximab) effectively resolved the intracoronary thrombus.

Implications:

  • Myocardial bridging distal to coronary lesions should be considered a potential risk factor for intracoronary thrombus formation during preprocedural evaluation.
  • This finding emphasizes the need for careful assessment of coronary anatomy in patients undergoing intervention.
  • Further research into the pathophysiology and management of myocardial bridging complications is warranted.